Subclinical Hypothyroidism (SCH) is an asymptomatic condition, diagnosed when peripheral thyroid hormone level are with in their normal laboratory reference range but serum thyroid stimulating hormone (TSH) levels are mildly elevated. It is more common in women than men, and its prevalence increases with age. Of patients with SCH, 80% have a serum TSH of less than 10 mIU/L. The most important implication of SCH is high likelihood of progression to clinical hypothyroidism and then to cardiovascular diseases. It has been associated with atherosclerotic cardiovascular disease even in the absence of hypercholesterolemia. The decision to treat SCH patients with Levothyroxine for restoring euthyroidism and improving cardiovascular risk should depend on the presence of risk factors, rather than on a TSH threshold. This study aims at determining the significance of early biochemical markers as effective tool for the detection of early cardiovascular risk in subclinical hypothyroid patients.

Ms.Ramandeeep kaur received her M.Pharm.degree in Pharmacy practice from Punjabi University India. Ms. Raman has attended several national and international conferences. She has to her credit several research publications and life membership of several national pharmaceutical associations.